INSIGHTS ON SOLID DOSE MANUFACTURING
-
![adare osd]( "Combining Powdose® And Diffucaps® For Precise Solid Oral Dosing")
Combining Powdose® And Diffucaps® For Precise Solid Oral DosingCombining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.
-
![Bora Pharmaceuticals - Zhunan Facility Site VR Tour]( "Zhunan Facility Site VR Tour")
Zhunan Facility Site VR TourBora’s 36,000-square-meter Zhunan, Taiwan facility delivers flexible, high-quality cGMP oral solid dose manufacturing with access to major markets including North America and the EU.
-
![GettyImages-1097562996-pill-tablet-capsule-OSD-oral-solid]( "Oral Delivery Of PROTACs: Integrating Molecular Design And Enabling Formulation")
Oral Delivery Of PROTACs: Integrating Molecular Design And Enabling FormulationExplore how integrated molecular design and formulation strategies can overcome the unique oral-delivery challenges of PROTACs, transforming complex degraders into viable, scalable medicines.
-
![Natoli - tool and tablet]( "Tablet Consistency And Punch Length – A Pragmatic Perspective For European Manufacturers")
Tablet Consistency And Punch Length – A Pragmatic Perspective For European ManufacturersTablet consistency relies on a balance of formulation, press mechanics, and tooling. Learn why punch length tolerance is often overstated and what other critical factors truly drive quality and uniformity.
-
Modeling Polymer Interactions To Improve Amorphous Solid Dispersion Stability7/15/2026
Molecular dynamics modeling revealed how hydrogen bonding between PVP and Eudragit drives stable amorphous solid dispersion formation, cutting formulation screening time significantly.
-
Breaking The GLP-1 Manufacturing Bottleneck: Single Use For Safer Scale Up9/23/2026
Streamline GLP-1 scale-up by replacing heavy container cleaning with single-use powder handling to boost containment and manufacturing capacity.
-
From Disruption To Reinvention: The Story Of API-In-Capsule Technology And Its Future8/19/2025
Discover how advanced API-in-capsule technology addresses previous limitations, providing a flexible and efficient path for drug candidates from development to clinical trials.
-
Safety First: Considerations When Formulating High Potency Compounds9/23/2026
Developing highly potent APIs comes with unique challenges. Explore strategies for managing risk, protecting personnel, and advancing programs with confidence.
-
HPAPI Containment: A Full Lifecycle Safety Innovation6/15/2026
Containing highly potent APIs across a full operational lifecycle requires a structured approach that addresses hazard scoring, quality by design, performance testing, and safe enclosure disposal.
SOLID DOSE MANUFACTURING SOLUTIONS
-
![digital research, biotech, scientific innovation-GettyImages-2223712673]( "Solutions For Your Oral Dose Challenges")
Oral dose development, manufacturing, packaging, and serialization under one quality system, supporting potent and controlled compounds from clinical supply through commercial launch.
-
![Pharmacontainment]( "Pharmaceutical Containment Systems, RABS, Isolators")
Inno4Life, part of the Dec Group, has in-depth knowledge and containment equipment solutions for the aseptic/sterile Fill-Finish pharmaceutical industry. In line with ISO 14644, including monitoring of viable and non-viable monitoring to comply with the most recent revisions of the ISPE containment specifications cGMP and GAMP5 guidelines.
-
![Natoli scientists]( "Pharmaceutical Preformulation Support Services")
Partner with Natoli Scientific during the earliest stages. Our scientific expertise with state-of-the-art analytical capabilities is ready to take any preformulation challenge.
Natoli scientific has an expertise of handling a wide range of APIs for the development of oral solids. We apply principles of ‘Quality by Design’ to define Critical Material Attributes (CMA), Critical Process Parameters (CPP), Critical Quality Attributes (CQA) and Quality Target Product Profiles (QTPP). Because we believe that understanding material and process as much as possible in the early life cycle of drug product development program is an insurance for further development path. Keeping your practices up to date with the ICHQ8 regulatory guidance issued by the US FDA. This is also a gate way for a smooth ride of product in the different stages of product development stages.
-
![LAF Downflow Booths For Weighting and Sampling Powders]( "LAF Downflow Booths For Weighing And Sampling Powders")
The LAF Downflow Booth provides product and personnel protection during the weighing or sampling of powdered substances through precise air circulation.
-
![Doctor holding antibiotic pills-GettyImages-2271436785]( "Commercial Manufacturing Solutions")
Scalable oral dose manufacturing, advanced containment, technology transfer expertise, and integrated support help reduce risk and ensure seamless progression to global commercial supply.
